Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Syngeneic B16-F1 cells are more efficient than allogeneic Cloudman cells as antigen source in DC-based vaccination in the B16-F1 murine melanoma model.

Mac Keon S, Bentivegna S, Levy EM, Marks MS, Mantegazza AR, Wainstok R, Mordoh J.

Vaccine. 2019 Aug 14;37(35):4947-4955. doi: 10.1016/j.vaccine.2019.07.018. Epub 2019 Jul 13.

2.

Selective hemangioma cell dysfunction and apoptosis triggered by in vitro treatment with imiquimod.

Rocco R, Alegre N, Pozner R, Wainstok R, Gazzaniga S.

Toxicol Lett. 2018 May 15;288:82-88. doi: 10.1016/j.toxlet.2018.01.016. Epub 2018 Feb 2.

PMID:
29410238
3.

Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models.

Mac Keon S, Ruiz MS, Gazzaniga S, Wainstok R.

Front Immunol. 2015 May 20;6:243. doi: 10.3389/fimmu.2015.00243. eCollection 2015. Review.

4.

Altered expression of cytokines in mice infected intranasally with two syncytial variants of Herpes simplex virus type 1.

Carolina Artuso M, Linero FN, Gazzaniga S, Scolaro LA, Pujol CA, Wainstok R, Josefina Carlucci M.

Microb Pathog. 2014 Jun-Jul;71-72:68-72. doi: 10.1016/j.micpath.2014.04.004. Epub 2014 Apr 24.

PMID:
24768928
5.

CD207⁺ cells recruitment to the vaccination site and draining lymph nodes after the administration of DC-Apo/Nec vaccine in mice.

Ruiz MS, Mac Keon S, Campisano S, Bravo AI, Gazzaniga S, Wainstok R.

Vaccine. 2014 Mar 5;32(11):1229-32. doi: 10.1016/j.vaccine.2014.01.025. Epub 2014 Jan 29.

PMID:
24486365
6.

Anti-melanoma vaccinal capacity of CD11c-positive and -negative cell populations present in GM-CSF cultures derived from murine bone marrow precursors.

Campisano S, Mac Keon S, Gazzaniga S, Ruiz MS, Traian MD, Mordoh J, Wainstok R.

Vaccine. 2013 Jan 2;31(2):354-61. doi: 10.1016/j.vaccine.2012.10.114. Epub 2012 Nov 10.

PMID:
23146677
7.

Decorin and biglycan expression: its relation with endothelial heterogeneity.

Calabrese GC, Gazzaniga S, Oberkersch R, Wainstok R.

Histol Histopathol. 2011 Apr;26(4):481-90. doi: 10.14670/HH-26.481.

PMID:
21360441
8.

Vaccination with dendritic cells charged with apoptotic/necrotic B16 melanoma induces the formation of subcutaneous lymphoid tissue.

Mac Keon S, Gazzaniga S, Mallerman J, Bravo AI, Mordoh J, Wainstok R.

Vaccine. 2010 Nov 29;28(51):8162-8. doi: 10.1016/j.vaccine.2010.09.095. Epub 2010 Oct 27.

PMID:
20937314
9.

A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression.

von Euw EM, Barrio MM, Furman D, Levy EM, Bianchini M, Peguillet I, Lantz O, Vellice A, Kohan A, Chacón M, Yee C, Wainstok R, Mordoh J.

J Transl Med. 2008 Jan 25;6:6. doi: 10.1186/1479-5876-6-6.

10.

Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft.

Gazzaniga S, Bravo AI, Guglielmotti A, van Rooijen N, Maschi F, Vecchi A, Mantovani A, Mordoh J, Wainstok R.

J Invest Dermatol. 2007 Aug;127(8):2031-41. Epub 2007 Apr 26.

11.
12.

Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells.

Liu K, Idoyaga J, Charalambous A, Fujii S, Bonito A, Mordoh J, Wainstok R, Bai XF, Liu Y, Steinman RM.

J Exp Med. 2005 Dec 5;202(11):1507-16.

13.
14.

Isolation and molecular characterization of a mouse renal microvascular endothelial cell line.

Gazzaniga S, González L, Mantovani A, Vecchi A, Wainstok R.

In Vitro Cell Dev Biol Anim. 2004 Mar-Apr;40(3-4):82-8.

PMID:
15311962
15.

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.

Goldszmid RS, Idoyaga J, Bravo AI, Steinman R, Mordoh J, Wainstok R.

J Immunol. 2003 Dec 1;171(11):5940-7.

16.

Inflammatory changes after cryosurgery-induced necrosis in human melanoma xenografted in nude mice.

Gazzaniga S, Bravo A, Goldszmid SR, Maschi F, Martinelli J, Mordoh J, Wainstok R.

J Invest Dermatol. 2001 May;116(5):664-71.

Supplemental Content

Loading ...
Support Center